All publications

Export 167 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
D
Dunn DT, UK HIV Drug Resistance Database.  2005.  Patterns of thymidine analogue mutations (TAMS) in samples sent for routine HIV drug resistance testing. 14th International HIV Drug Resistance Workshop, 7-11 June 2005.
Dunn DT, Coughlin K., Cane P A.  2011.  Genotypic resistance testing in routine clinical care. Curr Opin HIV AIDS. 6:251-7.
Dunn DT, von Wyl V., Price H., Asboe D.  2010.  The impact of the 0-0 cell on measures of amino acid covariation. AIDS. 24:159-60.
Dunn DT, Pillay D.  2007.  UK HIV drug resistance database: background and recent outputs. J HIV Ther. 12:97-8.
Dunn DT, Green H, Matthias R, Woodburn P, Gifford RJM, Chrystie I, Zuckerman M., Geretti AM, Loveday C, Clark J et al..  2004.  Prevalence of reduced drug susceptibility in treatment-naive patients in the UK. 13th International Drug Resistance Workshop, 8-12 June 2004.
E
Easterbrook P, Welz T, UK HIV Drug Resistance Database.  2006.  Impact of HIV-1 subtype on genotypic resistance to protease inhibitors in the United Kingdom. 13th Conference on Retroviruses and Opportunistic Infections, 5-8 February 2006.
El-Bouzidi K, White E, Mbisa JL, Sabin CA, Phillips AN, Mackie N, Pozniak A, Tostevin A, Pillay D, Dunn DT et al..  2016.  HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK. J Antimicrob Chemother. 71(12)
F
Foster GM, Ambrose JC, Hue S, Conibear T, Fearnhill E, Abecasis AB, Leigh Brown A, Geretti AM, UK HIV Drug Resistance Database.  2011.  Mapping the circulation of HIV-1 recombinants among MSM. 18th Conference on Retroviruses and Opportunistic Infections, 27 Feb - 2 Mar 2011.
Foster GM, Ambrose JC, Hue S, Delpech V, Fearnhill E, Abecasis AB, Leigh Brown A, Geretti AM.  2014.  Novel HIV-1 recombinants spreading across multiple risk groups in the United Kingdom: the identification and phylogeography of Circulating Recombinant Form (CRF) 50_A1D. PLoS One. 9:e83337.
Foster GM, Ambrose JC, Hue S, Delpech V, Fearnhill E, Leigh Brown A, Geretti AM, UK HIV Drug Resistance Database.  2012.  Transmission dynamics of CRF50_A1D across most at risk communities in the UK. 19th International HIV Dynamics & Evolution Conference, 25-28 April 2012.
Fox J, Castro H, Kaye S, McClure M, Weber JN, Fidler S.  2010.  Epidemiology of non-B clade forms of HIV-1 in men who have sex with men in the UK. AIDS. 24:2397-401.
Fox J, Dudaz A, Green H, Dunn DT, Kaye S, McClure M, Fidler S, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2007.  Epidemiology of non-B clade forms of HIV-1 in MSM in the UK. 13th Annual Conference of the British HIV Association, 25-28 April 2007.
G
Geretti AM, Sabin CA, Dunn DT, Nebbia G, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2005.  Mutations at reverse transcriptase (RT) codons G196, Q207, H208, R211 and I214 are associated with drug experience and specific RT mutation patterns. 14th International HIV Drug Resistance Workshop, 7-11 June 2005.
Geretti AM, Phillips AN, Kaye S, Booth C, Garcia A, Mackie N, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2008.  Prevalence and patterns of antiretroviral drug resistance at low plasma HIV RNA load levels. 17th International HIV Drug Resistance Workshop, 10-14 June 2008.
Geretti AM, White E, Beloukas A, Orkin C, Tostevin A, Tilston P, Chadwick D, Leen C, Sabin CA, Dunn DT et al..  2016.  Impact of Transmitted Thymidine Analogue Mutations on Responses to First-Line ART. Conference on Retroviruses and Opportunistic Infections (CROI) 2016.
Geretti AM, Phillips AN, Kaye S, Booth C, Mackie N, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2009.  Detection of clinically relevant antiretroviral drug resistance mutations among treated patients undergoing testing at low levels of viraemia. 18th International HIV Drug Resistance Workshop, June 2009.
Geretti AM, Harrison LJ, Green H, Dunn DT, UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study.  2008.  Effect of HIV-1 subtype on virological and immunological response to first-line HAART. 6th European HIV Drug Resistance Workshop, 26-28 March 2008.
Geretti AM, White E, Beloukas A, Orkin C, Tostevin A, Tilston P, Chadwick D, Leen C, Sabin CA, Dunn DT et al..  2016.  Impact of Transmitted Thymidine Analogue Mutations on Responses to First-Line ART. International HIV Drug Resistance Workshop 2016.
Geretti AM, White E, Orkin C, Tostevin A, Tilston P, Chadwick D, Leen C, Sabin C, Dunn DT.  2018.  Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance.. J Antimicrob Chemother.
Geretti AM, Harrison LJ, Green H, Sabin CA, Hill T, Fearnhill E, Pillay D, Dunn DT.  2009.  Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy. Clin Infect Dis. 48:1296-305.